StartUp Health March 18, 2025
This week’s global health innovation funding highlights include a $110M round for AI-driven drug discovery, major investments in genetic medicine, and digital health startups securing millions to advance chronic disease management, mental health, and neuroscience solutions.
This week’s reported global health innovation funding included:
Insilico Medicine, a Cambridge, MA-based clinical-stage generative AI-driven drug discovery company, raised $110M led by Value Partners Group, with participation from new and existing investors. source>
Arbor Biotechnologies, a Cambridge, MA-based biotech company discovering and developing genetic medicines, raised $73.9M led by ARCH Venture Partners and TCGX, with participation from QIA, Partners Investment, Revelation Partners, Kerna Ventures, Ally Bridge Group, Arrowmark Partners, Deep Track Capital, Piper Heartland Healthcare Capital, Surveyor Capital, Temasek, T. Rowe Price Associates,...
Today's Sponsors
Today's Sponsor